INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

82,081 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
WS
Wallace SusanVP & CHRO
CSLCARLISLE COMPANIES INC
Tax withholding
F$44K
128 sh
Jan 31, 2026Feb 2, 2026
Page 1629 of 2053
← PrevNext →
traded Jan 31, 2026
+2d
SEC Form 4

Evidence

13
MD
Maddox Mark DExecutive VP - Administration
APAAPA Corp
Option exercise
M—
6,158 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

13
HK
Henderson Tracey KExecutive VP Exploration
APAAPA Corp
Option exercise
M—
6,158 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

13
DB
Delco Albert BradEVP & CFO
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
1,600 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

13
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
420 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
MD
Maddox Mark DExecutive VP - Administration
APAAPA Corp
Tax withholding
F$64K
2,424 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

12
DB
Delco Albert BradEVP & CFO
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$134K
660 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$50K
444 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$67K
586 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$504K
68.5K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

10
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HR
Hasani RamiEVP, Chief Financial Officer
UWMCUWM Holdings Corp
Grant or award
A—
175.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$2,948
933 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
2,764 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
SK
Slupkowski KrzysztofChief Credit Officer
EQBKEQUITY BANCSHARES INC
Tax withholding
F$3,655
79 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Option exercise
M—
387 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,591 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
168.5K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
TB
Tadele BeimnetEVP & President, Restaurants
VYXNCR Voyix Corp
Option exercise
M—
4,941 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

9
CL
Contreras Lerdo de Tejada LeonardoDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HA
Holder AlisonChief Brand & Product Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
1,152 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
Thomas RagyDirector
CXMSprinklr, Inc.
Derivative conversion
C—
1,054 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
RR
Ross Scott RichardEVP & CIO
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
17.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
AN
Alibhai Imran NizamudinDirector, Chief Executive Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
115.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HH
Harris Isaac HosojiroDirector, SEE REMARKS
LITELumentum Holdings Inc.
Grant or award
A—
629 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
WA
Wolfe Adam AEVP, CLO & Chief Admin Officer
UWMCUWM Holdings Corp
Grant or award
A—
175.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
GD
Gray Larry DeanSVP OF INVENTORY MANAGEMENT
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TS
Thomas ShannonSenior Vice President
CMSCMS ENERGY CORP
Grant or award
A—
7,757 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$30K
268 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HW
Huddleston Debra WeissDirector
NONENONEPIMCO Asset-Based Lending Co LLC
Grant or award
A—
2,834 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MA
Montellano Najera Jose ASVP OF WESTERN STORE OPS/SALES
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
EXPIAGNT, Inc.
Option exercise
M—
39 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

9
KD
Kauh John Saewook M.D.Chief Medical Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
NT
Nguyen Anh TuSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
162.2K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$33K
294 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence